Clinical Trials Logo

Filter by:
NCT ID: NCT05057416 Not yet recruiting - Clinical trials for Cardiovascular Health

The Effect of Exercise Intensity on Adherence

Start date: December 2, 2021
Phase: N/A
Study type: Interventional

This study aims to advance the knowledge of a novel strategy of exercise to help people achieve the health benefits of exercise in less commitment time. As opposed to the traditionally recommended long periods (60 min) of moderate intensity exercise, this study will examine the effects of two exercise programs which consist of different intensities and repeated bouts of short intense exercise followed by rest periods. By incorporating short intense bouts of exercise, it may be possible that individuals enjoy this strategy of exercising more, which may influence them to continue to train in this way, increase their exercise levels in daily life and achieve exercise-related health benefits. Overall healthy women will be divided into a novel sprint interval training group or a high intensity interval training group or a traditional moderate intensity continuous training group. To evaluate the success of each training approach, a health-related quality of life questionnaire, one mile run test, weight, strength test and adherence to study requirements will be assessed over a 6-week period. The investigators hypothesize that the sprint interval training group will experience greatest strength measurements, will lose most body fat, have the greatest exercise benefits and will enjoy the novel training program more and will therefore adhere to the program more than the moderate continuous training group.

NCT ID: NCT05057234 Recruiting - Cancer Clinical Trials

PRecision Oncology Evidence Development in Cancer Treatment - Liquid

PREDiCTl
Start date: June 18, 2021
Phase: N/A
Study type: Interventional

The current standard of care for molecular characterization of tumors is tissue based next generation sequencing (NGS) panel. Liquid biopsies (ie blood) are of increasing interest and have been implemented as a diagnostic tool in some countries. This study compares tissue based and liquid based testing to evaluate the detection rate and cost consequence of using this new tool in BC.

NCT ID: NCT05057026 Terminated - Clinical trials for Depression, Anxiety Disorders

Impact of a Mental Health Support Program on of Medical Residents' Stigmatization Towards People With Lived Experience

Start date: October 5, 2021
Phase:
Study type: Observational

The program, called the Mental Health Practice Support Program, is designed to teach new tools and skills for working with patients with mental health concerns in a family practice setting. The program is also being evaluated for effectiveness.

NCT ID: NCT05056727 Terminated - Clinical trials for Renal Insufficiency, Chronic

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

STABILIZE-CKD
Start date: September 30, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of Sodium Zirconium Cyclosilicate (SZC), as adjunct to ACEi/ARB therapy (lisinopril or valsartan), on slowing CKD progression (assessed as the reduction in participant's glomerular filtration rate [eGFR] decline over time) in participants with hyperkalaemia or at high risk of hyperkalaemia.

NCT ID: NCT05055505 Completed - SARS-CoV2 Infection Clinical Trials

The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions

Start date: September 14, 2021
Phase: N/A
Study type: Interventional

This study will conduct an evaluation of a program that is being implemented SickKids / Toronto Public health that provides take-home saliva testing kits in schools. Operationally, there is a planned randomization so that all schools have an equitable chance to receive the intervention at various time periods during the planned operational roll-out, which will require a staggered implementation consistent with the stepped-wedge study design. This study will leverage this chance implementation to do a robust evaluation of the public health intervention. Schools that are not being rolled out to week one, will begin in the "control phase" (testing at an assessment center, primary care or acute care facility) and transition to the program "intervention phase" (take home saliva kits available at schools) at a randomly assigned time (wedge) over a 6-week period with all schools receiving the program by the end of the study. The investigators will evaluate the impact of the program on SARS-CoV-2 case identification in schools.

NCT ID: NCT05055492 Completed - SARS-CoV2 Infection Clinical Trials

The School SPIT Study - Elementary Schools in High COVID-19 Incidence Regions

Start date: September 14, 2021
Phase: N/A
Study type: Interventional

This study will conduct an evaluation of a program that is being implemented SickKids / Toronto Public Health that provides take-home saliva testing kits in schools. Operationally, there is a planned randomization so that all schools have an equitable chance to receive the intervention at various time periods during the planned operational roll-out, which will require a staggered implementation consistent with the stepped-wedge study design. This study will leverage this chance implementation to do a robust evaluation of the public health intervention. Schools that are not being rolled out to week one, will begin in the "control phase" (testing at an assessment center, primary care or acute care center) and transition to the program "intervention phase" (take home saliva kits available at schools) at a randomly assigned time (wedge) over a 6-week period with all schools receiving the program by the end of the study. The investigators will evaluate the impact of the program on SARS-CoV-2 case identification in schools.

NCT ID: NCT05055258 Terminated - Clinical trials for Angioedema, Hereditary, Types I and II

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

KVD824-201
Start date: September 27, 2021
Phase: Phase 2
Study type: Interventional

A study to assess whether different doses of KVD824 are effective in preventing attacks of Hereditary Angiodedema Type I or Type II.

NCT ID: NCT05055206 Completed - Oropharynx Cancer Clinical Trials

Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to see how practical it is to inject a radiotracer called 99m-Technetium Sulfur Colloid around the tumors for the imaging of patients with oropharyngeal cancer.

NCT ID: NCT05054816 Completed - Hearing Loss Clinical Trials

Speech Locator In-car Performance Evaluation

Start date: February 11, 2022
Phase: N/A
Study type: Interventional

Listeners will conduct sound quality ratings of recordings talkers in a moving car processed using three different microphone processing strategies: an investigational adaptive directional microphone, an omnidirectional microphone and a fixed directional microphone. Participants will listen to the recordings streamed via commercially-available and individually-prescribed hearing aids, and conduct ratings onsite in the lab. The procedure will involve a training session and within-subject repeated measures. Stimuli will be randomized.

NCT ID: NCT05054725 Active, not recruiting - Clinical trials for Non-Small Cell Lung Cancer

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

Start date: December 30, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the antitumor effects of sotorasib and RMC-4630 in subjects with KRASG12C mutant NSCLC